Pegilodecakin combined with pembrolizumab or nivolumab for patients with advanced solid tumours (IVY): a multicentre, multicohort, open-label, phase 1b trial.

ABSTRACT:

SUBMITTER: Naing A 

PROVIDER: S-EPMC8436252 | biostudies-literature | 2019 Nov

REPOSITORIES: biostudies-literature